Rita M. O'Connor - 22 Feb 2022 Form 4 Insider Report for PLx Pharma Inc.

Role
Chief Financial Officer
Signature
/s/ Rita M. O'Connor
Issuer symbol
N/A
Transactions as of
22 Feb 2022
Net transactions value
$0
Form type
4
Filing time
24 Feb 2022, 19:16:21 UTC
Previous filing
11 Aug 2021
Next filing
16 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLXPQ Stock Option (right to buy) Award $0 +110,000 $0.000000 110,000 22 Feb 2022 Common Stock 110,000 $4.99 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended.
F2 These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.